Report: Influenza vaccine effectiveness for the 2022/2023 season

Published Date: 02 Mar 2023

Influenza vaccination during the 2022-2023 season is recommended for the treatment of fever in children and adults under 65 years of age, flu symptoms in children, . ..

Read Full News

Latest News

Obesity Linked to Increased Severe Infection Risk

New research suggests obesity could be associated with as many as 1 in 10 infection-related deaths, globally.

Neonatal Seizures Tied to Mortality and Disability by Age 5

Neonatal seizures in infants born at or beyond 36 weeks of gestation are linked to notably higher in-hospital mortality; nearly 1 in 4 survivors develop epilepsy or cerebral palsy by 5 years of age.

Australia’s UCCs Can Contribute More to Disaster Management

If the federal government took maximum advantage of UCCs in IPCCs and general practice facilities, Australia could become one of the best prepared countries for disasters.

Communicating Bad News: A Practical Guide for Clinicians

Have you ever wondered how one conversation can change a patient’s life? Discover a six-step approach to delivering difficult news with honesty, empathy, and clarity.

Multifoetal Gestation in CKD Tied to Poor Pregnancy Outcomes

In women with CKD, multifoetal pregnancy is associated with notably increased odds of preterm delivery, having a baby born small for gestational age, and NICU admission.

Alcohol Counseling After US Dietary Guidelines Update

New US dietary guidelines may raise confusion for patients with chronic kidney disease. Experts suggest approaches for counseling.

Todays Updates

Improving Diabetic Macular Edema Care in Native American Communities: Real-World Insights and Culturally Responsive Approaches

Improving Diabetic Macular Edema Care in Native American Communities: Real-World Insights and Culturally Responsive Approaches

Targeting the PI3K/AKT/PTEN Pathway to Optimize Treatment for HR+/HER2- Breast Cancer

Targeting the PI3K/AKT/PTEN Pathway to Optimize Treatment for HR+/HER2- Breast Cancer

Navigating Treatment-Associated Adverse Events and Patient-Centered Supportive Care in HR+/HER2- Breast Cancer

Navigating Treatment-Associated Adverse Events and Patient-Centered Supportive Care in HR+/HER2- Breast Cancer

Optimizing Safe Administration of Novel Infusion Therapies in HR+/HER2- Advanced Breast Cancer

Optimizing Safe Administration of Novel Infusion Therapies in HR+/HER2- Advanced Breast Cancer

Optimizing Treatment Sequencing in Endocrine-Refractory HR+/HER2- Breast Cancer

Optimizing Treatment Sequencing in Endocrine-Refractory HR+/HER2- Breast Cancer

Evaluating the Latest Evidence on Emerging Somatostatin Receptor Ligands for Acromegaly

Evaluating the Latest Evidence on Emerging Somatostatin Receptor Ligands for Acromegaly

Navigating Advances in Cystic Fibrosis Care

Navigating Advances in Cystic Fibrosis Care

Todays Updates

Improving Diabetic Macular Edema Care in Native American Communities: Real-World Insights and Culturally Responsive Approaches

Improving Diabetic Macular Edema Care in Native American Communities: Real-World Insights and Culturally Responsive Approaches

Targeting the PI3K/AKT/PTEN Pathway to Optimize Treatment for HR+/HER2- Breast Cancer

Targeting the PI3K/AKT/PTEN Pathway to Optimize Treatment for HR+/HER2- Breast Cancer

Navigating Treatment-Associated Adverse Events and Patient-Centered Supportive Care in HR+/HER2- Breast Cancer

Navigating Treatment-Associated Adverse Events and Patient-Centered Supportive Care in HR+/HER2- Breast Cancer

Optimizing Safe Administration of Novel Infusion Therapies in HR+/HER2- Advanced Breast Cancer

Optimizing Safe Administration of Novel Infusion Therapies in HR+/HER2- Advanced Breast Cancer

Optimizing Treatment Sequencing in Endocrine-Refractory HR+/HER2- Breast Cancer

Optimizing Treatment Sequencing in Endocrine-Refractory HR+/HER2- Breast Cancer

Evaluating the Latest Evidence on Emerging Somatostatin Receptor Ligands for Acromegaly

Evaluating the Latest Evidence on Emerging Somatostatin Receptor Ligands for Acromegaly

Navigating Advances in Cystic Fibrosis Care

Navigating Advances in Cystic Fibrosis Care

Latest News

New research suggests obesity could be associated with as many as 1 in 10 infection-related deaths, globally.

Neonatal seizures in infants born at or beyond 36 weeks of gestation are linked to notably higher in-hospital mortality; nearly 1 in 4 survivors develop epilepsy or cerebral palsy by 5 years of age.

If the federal government took maximum advantage of UCCs in IPCCs and general practice facilities, Australia could become one of the best prepared countries for disasters.

Have you ever wondered how one conversation can change a patient’s life? Discover a six-step approach to delivering difficult news with honesty, empathy, and clarity.

In women with CKD, multifoetal pregnancy is associated with notably increased odds of preterm delivery, having a baby born small for gestational age, and NICU admission.

New US dietary guidelines may raise confusion for patients with chronic kidney disease. Experts suggest approaches for counseling.

News All Time

Lupus Nephritis Triple Therapy With Belimumab Shows Promise

Belimumab combined with standard induction therapy is effective and safe in patients with proliferative lupus nephritis, according to a real-world study.

High-Dose Oral Insulin Fails to Halt T1D Progression in Kids

In children with stage 1 type 1 diabetes, high daily doses of oral insulin for 1 year do not halt progression to dysglycemia or clinical diabetes, nor do they affect insulin autoantibody levels.

New Autoimmune Disease CAR T Results ‘a Tremendous Success’

In the rapidly moving field, questions remain regarding long-term safety, durability of remission, and the FDA’s approach to approvals.

Video Interpreters Improve Care for Deaf Patients

Presence of a live video interpreter during consultations may help improve some aspects of communication between doctors and patients with deafness.

Fasting Improves Crohn’s Disease Symptoms and Overweight

Time-restricted feeding within an 8-hour window calms disease activity and inflammation, data indicate.

NSCLC Survival Not Tied to Common Drugs + Immunotherapy Use

A cohort study examines whether the use of common medications is associated with worse outcomes in patients with lung cancer taking immunotherapy.

Bridging Therapy May Enable Early Stop to Steroids in RA

Most patients with newly diagnosed rheumatoid arthritis can successfully discontinue glucocorticoids after short-term bridging therapy, a new study shows.

Low-Dose OIT Safe for Preschoolers With Food Allergies

Low-dose oral immunotherapy is safe and generally well tolerated in preschoolers with single or multiple food allergies, new research finds.

Belimumab Monotherapy Matches Combination Therapy in SLE

Patients with systemic lupus erythematosus who receive belimumab monotherapy show comparable remission rates and disease control to those who receive combination therapy with immunosuppressants.

Do Nontraditional Med Students Have an Advantage?

From former engineers to parents of three, nontraditional med students may bring a professional maturity that could alter the clinical environment.

Genetic Testing for Autoinflammation: What Gives Best Yield?

A 10-year study shows that a multipronged approach using whole exome sequencing can improve diagnostic yield in patients with suspected autoinflammatory diseases.

Australian Doctors Push Back Against Insurer Contracts

Calling for greater regulation and transparency, Australian clinicians are objecting to what they consider to be restrictive private health insurer contracts.

Doctors Urged to Ask About Herbal Remedies

One in three patients uses herbal remedies with prescription medicines, prompting warnings over underreported interactions and hidden risks.

Global evidence highlights social roots of HPV vaccine hesitancy

Decisions about the HPV vaccine among adolescents and their families are influenced by a web of social, cultural and trust-related factors, beyond simple awareness or access, a Cochrane review finds.

Cervical cancer vaccine push has saved 1.4 million lives: Gavi

A three-year campaign to bring vaccines against human papillomavirus (HPV) to low-income countries has prevented 1.4 million cervical cancer deaths, the vaccine alliance Gavi said Monday.

Randomized trials show no evidence of non-specific vaccine effects

For more than three decades, researchers Christine Stabell Benn and Peter Aaby from the Bandim Health Project have conducted randomized trials involving thousands of children in Guinea-Bissau and Denmark to demonstrate so-called ...

Recommended News For You

Cancer After Weight Loss; How Older Adults Use the Healthcare System.

After all, Pulled Myeloma Drug May Help Treat the Illness.

No increased risk of childhood cancer near UK nuclear sites, study finds

Remote monitoring can improve recovery from cancer surgery

Sarah Ferguson was identified as having malignant melanoma. These are the most recent therapies.

Antitumor mRNA-based vaccines show potential against gastric cancer metastasis

New imaging technique identifies glioblastoma patients who would benefit from immunotherapy

Recommended Articles For You

Radioligand Therapy Advances: PSMA, Neuroendocrine, and Solid Tumor Clinical Insights 

All About Ferric Gluconate – The Best Source Of Iron For Anemia 

Beyond the Human Eye: How AI Is Redefining Brain Cancer Diagnosis Through Advanced Imaging 

Imaging in Peritoneal Neoplasms: Diagnostic Advances and Multimodal Treatment Strategies 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Study: One-week breast cancer radiotherapy proven as safe and effective as standard three-week treatment

2.

In advanced endometrial cancer, immunocheckpoint inhibitor-chemotherapy combination improves overall survival.

3.

First-Line Combination for Bladder Cancer Not Eligible for Cisplatin Just Misses Positive Outcome.

4.

AI Unlocks Benefits of Prostate Cancer Treatment.

5.

Q&A: How early cancer screening could save Canada nearly half a billion dollars over patients' lifetimes

1.

From Diagnosis to Recovery: A Comprehensive Guide to Dealing with Cystic Teratoma

2.

The Bloodstream Compass: A Comparative Clinical Review of Liquid Biopsy and AI in Predictive Oncology

3.

Obesity is a major risk factor for cancer

4.

Managing High Potassium Levels: A Comprehensive Guide to Veltassa 

5.

Understanding Acute Myeloid Leukemia (AML) and Its Survival Rates

1.

International Lung Cancer Congress®

2.

Future NRG Oncology Meeting

3.

Genito-Urinary Oncology Summit 2026

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option

2.

The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift

3.

Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary

4.

A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma

5.

Navigating the Complexities of Ph Negative ALL - Part IV

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot